# Exondys 51

NDC: 60923-284
Generic name: eteplirsen
Labeler / Manufacturer: Sarepta Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20160919

FDA application: NDA206488

## Active ingredients

- ETEPLIRSEN: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60923-284"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60923-284
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33bff678-7829-479e-9110-b8e33a0bc0aa